IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,024,971 ▲ 0.53% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL5.15▼ 0.02% USD/MXN16.95▼ 0.01% USD/CLP920.93▲ 0.84% USD/COP3,116▲ 1.71% USD/PEN3.35▼ 0.04% USD/ARS1,514▲ 0.17% USD/UYU40.18▲ 1.55% USD/PYG5,957▲ 0.99% USD/BOB11.50▲ 1.47% USD/DOP58.05▼ 0.45% USD/CRC450.21▲ 2.07% USD/GTQ7.62▲ 2.21% USD/HNL26.82▲ 0.34% USD/NIO36.62▲ 0.09% USD/VES789.35▲ 0.36% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 1.10% EUR/BRL6.00▼ 0.15% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,644.91 ▲ 0.53% MERVAL 3,024,971 ▲ 0.53% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Thursday, August 27, 2026

Brazil Politics - Brazil

Bolsonaro asks for names of those who approved Covid mRNA vaccines for children in Brazil

By · December 17, 2021 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The National Health Regulator (Anvisa) issued a note this Friday that it repudiates what it calls “threats” made by President Jair Bolsonaro yesterday in a live broadcast on social networks.

The Chief Executive publicly demanded the disclosure of the names of the public servants who approved the application of Pfizer’s covid-19 vaccine in children aged five to 11 years.

RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

(Watch video, Dr. Robert Malone, the original inventor of the mRNA and DNA vaccines)

“Anvisa is always ready to meet demands for information, but repudiates and vehemently repels any threat, explicit or veiled that will constrain, intimidate or compromise the free exercise of regulatory activities and the livelihood of our lives and families: our work, which is to protect the health of citizens,” says the agency in a statement signed by the directors and the president Antonio Barra Torres, appointed by Bolsonaro – but broken with the government.

According to Anvisa, the agency is the “focus and target of violent political activism.” Public servants are said to have already reported death threats to the police by anti-vaccine groups even before the approval of the immunizer for children.

“The public service performed here, concerning vaccine analysis, is based on science,” says the agency, which guarantees a work environment “free of internal pressures and averse to external pressures.”

What Anvisa does fail to mention, however, is that there is science in both directions. There are researchers and studies that consider vaccinations for children harmless and those that, on the contrary, consider vaccinations for children very dangerous.

Read also: Covid-19 – “It is ridiculous to consider vaccinating schoolchildren”, say Japanese experts

One of the biggest opponents of applying mRNA Covid vaccines on children is none other than the original “inventor” of exactly these mRNA and DNA vaccines that this debate is about, Dr. Robert Malone (see video above).

Anvisa also emphasizes that all its resolutions are directly or indirectly linked to the name of all our employees. Since Pfizer’s vaccine is already definitively registered in Brazil, the expansion of the target audience is made by the technical area and not only by the directors, who are usually more exposed in the media.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.